Old Web
English
Sign In
Acemap
>
Paper
>
Low-dose intermittent Alemtuzumab in Sézary Syndrome: clinical activity, toxicity profile and immunological findings in 17 patients.
Low-dose intermittent Alemtuzumab in Sézary Syndrome: clinical activity, toxicity profile and immunological findings in 17 patients.
2008
Mg Bernengo
Pietro Quaglino
Alessandra Comessatti
Michela Ortoncelli
Mauro Novelli
Francesco Lisa
Mt Fierro
Keywords:
Immunology
Alemtuzumab
Toxicity
Medicine
low dose
toxicity profile
Correction
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]